Literature DB >> 21555392

Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement.

Uwe Heemann, Daniel Abramowicz, Goce Spasovski, Raymond Vanholder.   

Abstract

KDIGO (Kidney Disease: Improving Global Outcomes) is an international independent body aiming to 'improve the care and outcomes of kidney disease patients worldwide, through the development and implementation of clinical practice guidelines'. Recently, the KDIGO work group has produced comprehensive clinical practice guidelines for the care of kidney transplant recipients (KTRs). The guideline makes recommendations for immunosuppression, graft monitoring, as well as prevention and treatment of infection, cardiovascular disease, malignancy and other complications that are common in KTRs, including haematological and bone disorders. Because most guidelines were 'soft' rather than 'strong', and because global guidelines need to be adapted and implemented into the regional context where they are used, the European Renal Best Practice (ERBP) Advisory Board appointed a work group of transplant nephrologists and surgeons to review the newest KDIGO guideline and comment on its relevance and applicability for European KTRs. In this article, we concentrate only on those guidelines which we considered worth amending or adapting. All guidelines not mentioned are fully endorsed.

Entities:  

Mesh:

Year:  2011        PMID: 21555392     DOI: 10.1093/ndt/gfr169

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  16 in total

Review 1.  Adherence in pediatric kidney transplant recipients: solutions for the system.

Authors:  Elizabeth A Steinberg; Mary Moss; Cindy L Buchanan; Jens Goebel
Journal:  Pediatr Nephrol       Date:  2017-03-27       Impact factor: 3.714

Review 2.  Egyptian clinical practice guideline for kidney transplantation.

Authors:  Ahmed A Shokeir; Saddam Hassan; Tamer Shehab; Wesam Ismail; Ismail R Saad; Abdelbasset A Badawy; Wael Sameh; Hisham M Hammouda; Ahmed G Elbaz; Ayman A Ali; Rashad Barsoum
Journal:  Arab J Urol       Date:  2021-01-03

Review 3.  Interventions for preventing bone disease in kidney transplant recipients.

Authors:  Suetonia C Palmer; Edmund Ym Chung; David O McGregor; Friederike Bachmann; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2019-10-22

4.  Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment?

Authors:  I Rebollo-Mesa; E Nova-Lamperti; P Mobillo; M Runglall; S Christakoudi; S Norris; N Smallcombe; Y Kamra; R Hilton; S Bhandari; R Baker; D Berglund; S Carr; D Game; S Griffin; P A Kalra; R Lewis; P B Mark; S Marks; I Macphee; W McKane; M G Mohaupt; R Pararajasingam; S P Kon; D Serón; M D Sinha; B Tucker; O Viklický; R I Lechler; G M Lord; M P Hernandez-Fuentes
Journal:  Am J Transplant       Date:  2016-08-08       Impact factor: 8.086

5.  Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.

Authors:  Marie Matignon; Caroline Pilon; Morgane Commereuc; Cynthia Grondin; Claire Leibler; Tomek Kofman; Vincent Audard; José Cohen; Florence Canoui-Poitrine; Philippe Grimbert
Journal:  PLoS One       Date:  2017-06-27       Impact factor: 3.240

6.  Hepatitis C Infection Become a Common Issue Among Hemodialysis Patients in a Hemodialysis Center Jakarta, Indonesia, and Survival Comparison of Hemodialysis Patients with Hepatitis Infection between Two Hemodialysis Centers in Jakarta, Indonesia, and Penang, Malaysia.

Authors:  Diana Laila Ramatillah; Syed Azhar Syed Sulaiman; Amer Hayat Khan
Journal:  J Glob Infect Dis       Date:  2018 Apr-Jun

7.  Natural Killer Cells Promote Kidney Graft Rejection Independently of Cyclosporine A Therapy.

Authors:  Muhammad Imtiaz Ashraf; Attia Sarwar; Anja A Kühl; Elena Hunger; Arne Sattler; Felix Aigner; Heinz Regele; Martina Sauter; Karin Klingel; Stefan Schneeberger; Thomas Resch; Katja Kotsch
Journal:  Front Immunol       Date:  2019-09-24       Impact factor: 7.561

Review 8.  Complement Components in the Diagnosis and Treatment after Kidney Transplantation-Is There a Missing Link?

Authors:  Małgorzata Kielar; Agnieszka Gala-Błądzińska; Paulina Dumnicka; Piotr Ceranowicz; Maria Kapusta; Beata Naumnik; Grzegorz Kubiak; Marek Kuźniewski; Beata Kuśnierz-Cabala
Journal:  Biomolecules       Date:  2021-05-21

Review 9.  Risk models to predict chronic kidney disease and its progression: a systematic review.

Authors:  Justin B Echouffo-Tcheugui; Andre P Kengne
Journal:  PLoS Med       Date:  2012-11-20       Impact factor: 11.069

10.  The Peripheral NK Cell Repertoire after Kidney Transplantation is Modulated by Different Immunosuppressive Drugs.

Authors:  Christine Neudoerfl; Bernadett J Mueller; Cornelia Blume; Kerstin Daemen; Maja Stevanovic-Meyer; Jana Keil; Frank Lehner; Hermann Haller; Christine S Falk
Journal:  Front Immunol       Date:  2013-02-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.